These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8060915)

  • 1. Altered expression of NU-T2-BMZ antigen and type VII collagen in basal cell epithelioma.
    Yasaka N; Kawabe K; Furue M; Tamaki K; Ishibashi Y
    J Dermatol Sci; 1994 Apr; 7(2):136-41. PubMed ID: 8060915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical alterations in basement membrane components in skin cancer].
    Oguro K
    Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):105-13. PubMed ID: 2072578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. βKlotho expression is reduced in human non-melanoma skin cancer.
    Nakai K; Yoneda K; Haba R; Kushida Y; Katsuki N; Moriue J; Moriue T; Koura A; Yokoi I; Ishikawa E; Inoue S; Kubota Y
    Int J Dermatol; 2015 Oct; 54(10):e431-3. PubMed ID: 26234379
    [No Abstract]   [Full Text] [Related]  

  • 4. Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease.
    Zhang XM; Horiguchi Y; Ueda M; Yoshiki T; Imamura S
    J Dermatol Sci; 1992 Jan; 3(1):46-55. PubMed ID: 1591227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of seborrheic keratoses and basal cell epitheliomas by complement immunofluorescence and electron microscopy.
    Kimura S; Yamasaki Y; Nishikawa T; Kurihara S; Hatano H
    Acta Derm Venereol; 1980; 60(3):203-7. PubMed ID: 6158221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
    Mihailovici MS; Teleman S; Ungureanu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIPK2 expression in progression of cutaneous epithelial neoplasm.
    Kwon MJ; Min SK; Seo J; Kim DH; Sung CO; Lim MS; Cho J; Park HR
    Int J Dermatol; 2015 Mar; 54(3):347-54. PubMed ID: 25711204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bcl-2 expression in epidermal keratinocytic diseases.
    Nakagawa K; Yamamura K; Maeda S; Ichihashi M
    Cancer; 1994 Sep; 74(6):1720-4. PubMed ID: 8082073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.
    Onodera H; Nakamura S; Sugai T
    Am J Dermatopathol; 1996 Dec; 18(6):580-8. PubMed ID: 8989929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of SKALP/Elafin in human epidermal tumors.
    Alkemade HA; Molhuizen HO; van Vlijmen-Willems IM; van Haelst UJ; Schalkwijk J
    Am J Pathol; 1993 Dec; 143(6):1679-87. PubMed ID: 8256855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basement membrane zone remodeling during appendageal development in human fetal skin. The absence of type VII collagen is associated with gelatinase-A (MMP2) activity.
    Karelina TV; Bannikov GA; Eisen AZ
    J Invest Dermatol; 2000 Feb; 114(2):371-5. PubMed ID: 10652000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha with progression of keratinocytic neoplasms.
    Lining X; Uchi H; Hayashida S; Tsuji G; Kido M; Nakahara T; Takeuchi S; Takahara M; Moroi Y; Furue M
    J Dermatol Sci; 2009 Nov; 56(2):135-6. PubMed ID: 19660915
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical expression of cyclooxygenase-2 in skin cancers.
    Kagoura M; Toyoda M; Matsui C; Morohashi M
    J Cutan Pathol; 2001 Jul; 28(6):298-302. PubMed ID: 11401676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal cell carcinomas display extensive abnormalities in the hemidesmosome anchoring fibril complex.
    Korman NJ; Hrabovsky SL
    Exp Dermatol; 1993 Jun; 2(3):139-44. PubMed ID: 8162330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of Langerhans cells and expression of class II antigens on keratinocytes in malignant and benign epithelial tumors of the skin: an immunohistopathologic study with monoclonal antibodies.
    Chen HD; Zhao YM; Sun G; Yang CY
    J Am Acad Dermatol; 1989 Jun; 20(6):1007-14. PubMed ID: 2474010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of endothelins and their receptors in nonmelanoma skin cancers.
    Zhang Y; Tang L; Su M; Eisen D; Zloty D; Warshawski L; Zhou Y
    J Cutan Med Surg; 2006; 10(6):269-76. PubMed ID: 17241596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours.
    Fuller LC; Allen MH; Montesu M; Barker JN; Macdonald DM
    Br J Dermatol; 1996 Jan; 134(1):28-32. PubMed ID: 8745882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.